Notice2024-21060
Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 17, 2024
Issuing agencies
Justice DepartmentDrug Enforcement Administration
Abstract
Eli-Elsohly Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 180 (Tuesday, September 17, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 180 (Tuesday, September 17, 2024)]
[Notices]
[Page 76152]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-21060]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1432]
Bulk Manufacturer of Controlled Substances Application: Eli-
Elsohly Laboratories
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Eli-Elsohly Laboratories has applied to be registered as a
bulk manufacturer of basic class(es) of controlled substance(s). Refer
to Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
November 18, 2024. Such persons may also file a written request for a
hearing on the application on or before November 18, 2024.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to <a href="https://www.regulations.gov">https://www.regulations.gov</a> and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on <a href="https://www.regulations.gov">https://www.regulations.gov</a>. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on August 16, 2024, Eli-Elsohly Laboratories, 5
Industrial Park Drive, Oxford, Mississippi 38655-5343, applied to be
registered as a bulk manufacturer of the following basic class(es) of
controlled substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Marihuana Extract...................... 7350 I
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
Dihydromorphine........................ 9145 I
Amphetamine............................ 1100 II
Methamphetamine........................ 1105 II
Cocaine................................ 9041 II
Codeine................................ 9050 II
Dihydrocodeine......................... 9120 II
Oxycodone.............................. 9143 II
Ecgonine............................... 9180 II
Thebaine............................... 9333 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
for product development reference standards. In reference to drug codes
7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans
to isolate these controlled substances from procured 7350 (Marihuana
Extract). In reference to drug code 7360, no cultivation activities are
authorized for this registration.
In reference to drug code 9333 (Thebaine), the company plans to
manufacture a Thebaine derivative. No other activities for these drug
codes are authorized for this registration.
Marsha L. Ikner,
Acting Deputy Assistant Administrator.
[FR Doc. 2024-21060 Filed 9-16-24; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on September 17, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.